Tauroursodeoxycholate improves zoledronate-induced vascular endothelial dysfunction by suppressing the GCN2/eIF2α and IRE1/JNK pathways: a potential treatment option for MRONJ.

Tudcabil (tauroursodeoxycholic acid) - Bruschettini

zoledronic acid - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/42178285

Chengzhi Zhao; Jian Pan; Qizhang Wang; Xueer Zhou; Zhiwei Cao; Zijian Pan

May 25, 2026